These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8689271)

  • 1. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular actions and pharmacology of the calcium channel blocking drugs.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Med; 1984 Aug; 77(2B):2-10. PubMed ID: 6486125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of calcium in the regulation of normal vascular tone and in arterial hypertension].
    Ramón de Berrazueta J
    Rev Esp Cardiol; 1999; 52 Suppl 3():25-33. PubMed ID: 10614146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonism in vascular smooth muscle cells.
    Fleckenstein-Grün G
    Pflugers Arch; 1996; 432(3 Suppl):R53-60. PubMed ID: 8994543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY; DeBernardis JF
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcium on vascular smooth muscle tone.
    Morgan KG; Suematsu E
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):291S-298S. PubMed ID: 2078315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
    Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
    Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction.
    Cogolludo A; Moreno L; Lodi F; Tamargo J; Perez-Vizcaino F
    Cardiovasc Res; 2005 Apr; 66(1):84-93. PubMed ID: 15769451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.